Health Affairs October 1, 2024
Olivier J. Wouters, Jouni Kuha

Abstract

Little is known about how long it takes for new medicines to reach countries with different income levels. We analyzed data, sourced from IQVIA, on the timing of new drug launches in seventy-five low-, middle-, and high-income markets from 1982 to 2024. The sample captured the majority of essential medicines (as designated by the World Health Organization in the twenty-third Model List of Essential Medicines) that first came into medical use anywhere globally from 1982 onward. Kaplan-Meier estimates were used to quantify delays in launches across countries. Our analysis comprised 119 medicines with 6,871 observed...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Patient / Consumer, Provider, Survey / Study, Trends
STAT+: Trump’s FDA director pick has a history of criticizing the agency. Here are seven examples
Seniors deserve timely access to care, not bureaucratic hurdles | Viewpoint
Digital Doctors Are Coming. Regulators Need to Catch Up.
Trump names nominees to lead CDC, FDA, and his pick for surgeon general
Trump Nominates Physicians for CDC Director, Surgeon General

Share This Article